Does Mounjaro Cause Muscle Loss? GLP-1 Medicines and Lean Mass

Why does weight loss include muscle at all?

Whenever the body loses a large amount of weight — through dieting, weight-loss surgery or GLP-1 medicines — some of that loss is lean tissue, not only fat. GLP-1 receptors are not found in human skeletal muscle, so these medicines do not attack muscle directly. Instead, the muscle change is an indirect result of eating less and losing weight quickly. In other words, this is largely a feature of rapid weight loss in general, not a unique toxic effect of the drug.

What the trials actually found

Two landmark trials measured body composition with DEXA scans:

These numbers sound high, but two cautions apply. First, DEXA and similar scans have a measurement error of roughly 10–15% on lean mass, so any single percentage is approximate. Second, "lean mass" is not the same as "muscle": it includes water and other tissue, and some early loss is fluid. Reviews of the wider evidence give a broad range (around 15–60% of weight loss as lean mass) precisely because methods and populations differ.

Is it worse with Mounjaro than Wegovy?

You may have read that tirzepatide causes more muscle loss than semaglutide. Some observational data point that way, but there is no head-to-head randomised trial confirming a real difference, and tirzepatide also tends to produce more total weight loss, which changes the comparison. The honest position in 2026 is that the two are broadly similar in the proportion of lean mass lost, and the practical advice is the same for both.

Who is most at risk?

• Older adults (roughly 60 and over), who have less muscle to start with and rebuild it more slowly.
• People with already-low muscle mass or "sarcopenic obesity" (low muscle alongside excess fat).
• Anyone losing weight very fast or eating very little protein.

There is also a small effect on bone: semaglutide has been associated with modest reductions in bone mineral density over a year, and the Wegovy product information notes a fracture caution. This is another reason weight loss is best done with strength exercise and good nutrition, and with your clinician aware of your bone health if you are higher risk.

How to protect your muscle (what actually works)

Two things have the strongest evidence for keeping muscle during weight loss:

• Resistance (strength) exercise at least twice a week — working the major muscle groups. This is the single most effective way to signal your body to keep muscle. The NHS has free guidance on strength and flexibility exercises.
• Enough protein, spread through the day. Research on preserving muscle during weight loss often points to protein intakes in the region of 1.2–1.6 g per kg of body weight per day, split across meals — but the right amount depends on your age, kidney health and other conditions, so ask your GP or a dietitian for a target that is safe for you.

Losing weight a little more gradually, and staying active day to day, also helps. If you are older or already have low muscle, it is worth raising this with your clinician before or soon after starting a GLP-1 medicine.

Are there medicines to prevent muscle loss?

This is an active research area, but the honest answer for UK patients is: not yet. Several muscle-preserving drugs are being tested alongside GLP-1 medicines in clinical trials — for example bimagrumab and trevogrumab, which block muscle-limiting signalling pathways. Early phase 2 results are encouraging (some studies preserved lean mass while fat loss continued), but as of 2026 these agents are investigational only: they are not licensed or available for this use in the UK, and their long-term safety and benefit are still being established. Be very cautious of anyone marketing "muscle-preserving" peptides or drugs for weight loss online — that is not a recognised or safe route.

Related reading